• Study of levodopa and carbidopa treatment for patients with neurodevelopmental disorder caused by CTNNB1 gene mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of intraperitoneal paclitaxel combined with systemic therapy versus systemic therapy alone for patients with gastric cancer and peritoneal metastases

    Recruiting

    3 1 1 1
    Italy The Netherlands Norway Sweden
  • Study of High-Flow Nasal Oxygen During Intubation in Intensive Care Patients with Low Blood Oxygen Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of risankizumab safety and effectiveness in children and teenagers aged 2-17 years with moderate to severe ulcerative colitis

    Recruiting

    3 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Germany Greece Italy Spain Sweden
  • A study of LTP001 in combination with standard treatment for adults with pulmonary arterial hypertension

    Recruiting

    1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Czechia France Germany Greece Italy +6
  • Evaluating kidney cancer aggressiveness using Rubidium Chloride PET scan imaging in patients with renal cell carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of crinecerfont oral solution in children under 2 years old with congenital adrenal hyperplasia to evaluate safety and how the drug works in the body

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study of ONL1204 eye injections to slow vision loss in patients with age-related macular degeneration and geographic atrophy

    Recruiting

    2 1
    Investigated Drugs:
    Austria Czechia Germany Greece Hungary Italy +3
  • Study of intrathecal S230815 to evaluate safety and effectiveness in children with KCNT1-related Developmental and Epileptic Encephalopathy

    Recruiting

    2 1 1
    Investigated Drugs:
    France Italy Spain
  • Study of tildrakizumab to treat patients with chronic spontaneous urticaria who did not respond to previous treatments

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Germany

powered by